Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1992-02-05
1996-07-23
Scheiner, Toni R.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
435 721, 435 692, 435183, 436530, 436531, 5303871, G01N 33567, G01N 33544, G01N 33545, C12Q 168
Patent
active
055388450
ABSTRACT:
A method for identifying compounds capable of inhibiting the production of .beta.-amyloid peptide in cells comprises exposing cultured cells in one or more test compounds. The cells are cultured under conditions which produce amyloid precursor protein and which result in intracellular accumulation of an approximately 22 kD polypeptide which includes the entire sequence of the .beta.-amyloid peptide. Test compounds which cause a change in the accumulation of the 22 kD polypeptide are considered likely candidates for use as drugs for treating .beta.-amyloid diseases, such as Alzheimer's disease.
REFERENCES:
patent: 5221607 (1993-06-01), Cordell et al.
Kang et al. (1987) Nature 325:773-776.
Ponte et al. (1988) Nature 331:525-527.
Kitaguchi et al. (1988) Nature 331:530-532.
Weidemann et al. (1989) Cell 57:115-126.
Oltersdorf et al. (1990) J. Biol. Chem. 265:4492-4497.
Esch et al. (1990) Science 248:1122-1124.
Tamoake et al. (1991) Am. Assoc. Neuropathol. Abstr. 149 Golde et al. (1991) Soc. Neuroscience Abstr. 17:1293.
Tamaoka et al. (1992) Proc. Natl. Acad. Sci. USA 89:1345-1349.
Knops et al. "Evidence for a Nonsecretory Acidic Degradation Pathway for Amyloid Precursor Protein in 293 cells", J. Biol. Chem., 267(23):16022-16024 (Aug. 15, 1992).
Ezzell, "Alzheimer's Alchemy", Science News, 141: 152-153 (Mar. 7, 1992).
Morris et al. "The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)", Neurobiology, 39:1159-1165 (Sep. 1989).
Yankner et al, "Neurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease", Science 245:417-420 (28 Jul. 1989).
M. A. Winkler, "Tacrine for Alzheimer's Disease", JAMA, 271(13): 1023-1024 Apr. 6, 1994).
Knops Jeroen
Sinha Sukanto
Athena Neurosciences, Inc.
Duffy Patricia A.
Eli Lilly and Company
Scheiner Toni R.
LandOfFree
Beta-amyloid peptide production inhibitors and methods for their does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Beta-amyloid peptide production inhibitors and methods for their, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Beta-amyloid peptide production inhibitors and methods for their will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-712113